Table 2.
Study | Scaling Method | Respondents | Mode of Administration | Source of Health State Descriptions | Country |
---|---|---|---|---|---|
Lubitz et al77 (2017) | EQ-5D, SF-6D, HUI-2, HUI-3 | Patients | Trained interviewer or mail; Subsequent surveys conducted online | Own health (implied) | USA |
Choi et al78 (2013) | VAS | Clinicians | Initial rating unclear; intrarater reliability assessed by mail survey | Most common conditions in terms of histologic types and stages (ICD-10, C73) | South Korea |
Esnaola et al62 (2001) | TTO | Clinicians | Unclear | Investigator-proposed | USA |
Kent et al79 (2015) | SF-6D | Patients | Mail or telephone | Own health (implied) | USA |
Fordham et al76 (2015) | TTO | General public | Face-to-face interviews | Vignettes designed through a qualitative study with patients and clinicians | United Kingdom |
Borget et al80 (2015) | EQ-5D | Patients | Unclear | Own health (implied) | France |